Antitumoral macrolides

Details for Australian Patent Application No. 2009265629 (hide)

Owner Pharma Mar, S.A.

Inventors Reyes Benitez, Jose Fernando; Fernandez Rodriguez, Rogelio; Cuevas Marchante, Maria Del Carmen; Francesch Solloso, Andres; Crespo Sueiro, Gloria

Agent Shelston IP

Pub. Number AU-A-2009265629

PCT Pub. Number WO2010/000817

Priority 08380195.1 03.07.08 EP

Filing date 2 July 2009

Wipo publication date 7 January 2010

International Classifications

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 35/00 (2006.01) Antineoplastic agents

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/000817 Priority application(s): WO2010/000817

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009265631-Cellular COPD diagnosis

2009265623-Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers